Spike S1 RBD (B.1.351, Beta Variant) (SARS-CoV-2): ACE2 Inhibitor Screening Chemiluminescence Ass... 返回列表页

The Spike S1 RBD-B.1.351 (SARS-CoV-2): ACE2 Inhibitor Screening Chemiluminescence Assay Kit is designed for screening and profiling inhibitors of the interaction of ACE2 with the RBD region of the B.1.351 variant of the SARS-CoV-2 Spike S1 protein. The key to this kit is the high sensitivity of detection of ACE2-Biotin protein by Streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, Spike S1 RBD-B.1.351 is coated on a 96-well transparent plate. Next, ACE2-Biotin is incubated with Spike S1 RBD-B.1.351 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can then be measured using a luminometer or microplate reader capable of reading chemiluminescence.

Assay Principle